Безболевая ишемия миокарда, нарушения вегетативной регуляции сердечной деятельности и эластических свойств артерий у женщин с ревматоидным артритом
Диссертация
Установлено, что повышение артериальной ригидности (АР) регистрируют уже на ранних стадиях ССЗ, а по данным проспективных исследований снижение эластических свойств артериальной стенки рассматривается как независимый фактор риска ССО у лиц без явного поражения сердечно-сосудистой системы и у больных АГ, ИБС, ХСН, СД 2 типа. Показано, что повышение уровня лейкоцитов, СОЭ, СРБ, ИЛ-6, ФНОа является… Читать ещё >
Список литературы
- Попкова Т.В., Новикова Д. С., Насонов E.J1. Атеросклероз при ревматических заболеваниях. В кн.: Ревматология: клинические рекомендации. М., Геотар-Медиа, 2010−678−702.
- Meune C., Touze E., Trinqurte L., Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and metaanalysis of cohort studies. Rheumatology 2009−48:1309−13.
- Meune С., Тоигё E., Trinquart L., Allanore Y. High risk of clinical cardiovascular events in RA: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 2010−103:253−61.
- Warrington K.J., Kent P.D., Frye R.L. et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 2005−7:R984−91.
- Douglas K.M., Pace A.V., Treharne G.J. et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2006−65:348−53.
- Sodergren A., Stegmayr В., Lundberg V., Ohman M.L., Wallberg-Jonsson S. Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 2007−66:263−6.
- Maradit-Kremers H., Crowson C.S., Nicola P.J. et al. Increased unrecognized coronary heart disease and sudden deaths rheumatoid arthritis. A population-based controlled study. Arthritis Rheum 2005−52: 402−11.
- Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., Gabriel S.E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005−52:722−32.
- Стрюк Р.И., Леонова E.A., Гостева O.B., Тедикова Н. С. Безболевая ишемия миокарда у больных ревматоидным артритом. Тер архив 2008−5:16−20.
- Galiutina О., Bychak O.V. Relationship of silent myocardial ischiemia with the course of rheumatoid arthritis and hyperhomocysteinemia. Lik Sprava 2011- 1−2:4852.
- Леонова E.A., Стрюк P. И. Оценка суточного мониторирования ЭКГ у больных ревматоидным артритом. Научно-практическая ревматология 2006−2:94.
- Wislowska М., Sypula S., Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int 1999- 18(5−6): 163−9.
- Махнырь Е.Ф., Голоухова Л. М., Головко E.B. и соавт. Нарушения ритма сердца у больных ревматоидным артритом как проявление ревматоидной болезни сердца. Вестник Российского государственного медицинского университета 2009−7:45−8.
- Seforovic P.M., Ristic A.D., Maksimovic R. et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic disease. Rheumatology 2006- 45: iv39-iv42.
- Crowson C.S., Gabriel S.E. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011 -70(5):719−21.
- Leuven S.I., Franssen R., Kastelein J.J. et al. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008−47:3−7.
- Hall F.C., Dalbeth. Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology (Oxford) 2005−44(12): 1473−82.
- Koopman F.A., Stoof S.P., Straub R.H. et al. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med 2011−17(9−10):937−48.
- Новикова Д.С., Попкова T.B., Маркелова Е. И. и соавт. Клиническое значение оценки вариабельности ритма сердца у больных ревматоидным артритом. Клиническая медицина 2009- 1:27—32.
- Аничков Д.А., Платонова А. А. Клиническое значение показателей вариабельности сердечного ритма (по данным 5-минутных и 24-часовых записей ЭКГ) у больных ревматоидным артритом. Рациональная фармакотерапия 2009−1:77−82.
- Cook S., Togni М., Schaub М. et al. High heart rate: a cardiovascular risk factor? Eur Heart J 2006−27:2387−93.
- Goldberg R.J., Larson M., Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med 1996- 156:505−10.
- Schwartz R.J. The neural control of heart rate and risk stratification after myocardial infarction. Eur Heart J 1999-l (Suppl H):H33-H43.
- Dyer A.R., Persky V., Stamler J. et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980−112:736−49.
- Kannel W.B., Kannel C., Paffenbarger R.S. et al. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987- 113:1489−94.
- Wannamethee G., Shaper A.G., Macfarlane P.W. et al. Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995−91:1749−56.
- Gillum R., Makus D., Feldman J. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991−121:172−7.
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996- 93:1043−65.
- Wolf M.M., Varigos G.A., Hunt D., Sloman J.G. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978- 15(2):52−3.
- Kleiger R.E. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987- 59:256−62.
- Bigger J.T. Frequency domain measures of heart period variability and mortality rate after myocardial infarction. Circulation 1992- 85:164−71.
- Tapanainen J.M., Thomsen P.E., Kober L. et al. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 2002: 90:347−52.
- Yi G., Goldman J.H., Keeling P.J. et al. Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 1997: 77(2): 10 814.
- Nolan J., Batin P.D., Andrews N. et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 1998- 98:1510−6.
- Schroeder E.B., Chambless L.E., Liao D. et al. Diabetes, glucose, insulin and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes care 2005- 28(3):668−74.
- Ko S.H., Song K.H., Park S.A. et al. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabet Med 2008- 25(10): 1171−7.
- Huikuri H., Ylitalo A., Pikkujamsa S.M. et al. HR variability in systemic hypertension. Am J Cardiol 1996- 77(12): 1073−7.
- Park S.K., Schwartz J., Weisskopf M. et al. Low-level lead exposure, metabolic syndrome, and heart rate variability: The VA normative aging study. Environ Health Perspect 2006- U4(ll):1718−24.
- Никитин Ю. П., Кузнецов А. А., Малютина С. К. и др. Прогностическое значение длительности и дисперсии интервалов Q—Т и R—R в общей популяции Новосибирска. Кардиология 2002−2:76−83.
- Higham P. D., Furniss S. S., Campbell R. et al. QT dispersion and components of the QT interval in ischemia and infarction. Br Heart J 1995−73:32−6.
- Dobson C.P., Larovere M.T., Olsen C. et al. 24-Hour QT variability in heart failure. J Electrocardiol 2009−42(6):500−4.
- Watanabe E., Arakawa T. Uchiyama T. et al. Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure. Heart rhytm 2007−4(8):999−1005.
- Ziegler D., Zentai C.P., Perz S. et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MON-ICA/KORA Augsburg Cohort Study. Diabetes Care 2008−31(3): 556−61.
- Elming H., Holm E., Jun L. et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998−19:1391−400.
- De Bruyne M.C., Hoes A.W., Kors J.A. et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. Eur. Heart J 1999−20:278−84.
- Макаров M. Оценка интервала QT при холтеровском мониторировании. www.medass.ru/news/con2003/p345356.doc
- О.С. Сычев, О. А. Епанчинцева, Е. Н. Романова, Д. Т. Малидзе, Т. В. Гетьман. Интервал Q-T и показатели вариабельности ритма сердца у больных с ишемической болезнью сердца и желудочковыми аритмиями. http://www.rql.com.Ua/cardioj/2003/5/sychov.htm
- Ridker P.M., Rifai N., Stampfer M.J. et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000, 101, 1767−72.
- E.JI. Насонов. Иммунологические маркеры атеросклероза. В кн.: Антифос-фолипидный синдром. М., Литтера, 2004, 278 98.
- Danesh J., Kaptoge S., Mann A.G. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Medicine, 2008, 5 (e78), 0600 0610.
- Kuo L.T., Yang N.I., Cherng W.J. Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity. Int. Heart J., 2008, 49, 391 402.
- Libby P., Ridker P. M, Maseri A. Inflammation and atherosclerosis. Circulation, 2002, 105, 1135−43.
- Hansson G.K. Inflammation, atherosclerosis and coronary artery disease. N. Eng. J. Med., 2005, 352, 1685−95.
- Sajadieh A., Nielsen O., Rusmussen V. et al. Increased heart rate and reduced heart rate variability are associated with subclinical inflammation in middle-age and elderly subjects with no apparent heart diseases. Eur. Heart J., 2004, 25, 363 70.
- Коп H., Nagano M., Tanaka F et al. Association of decreased variation of R-R interval and elevated serum C-reactive protein level in a general population in Japan. Int. Heart J. 2006, 47, 867 76.
- Sloan R.P., McCreath H., Tracey K.J. et al. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007, 13, 178 84.
- Marsland A.L., Gianaros P.J., Prather A.A. et al. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med2007, 8, 709−716.
- Lampert R., Bremner J.D., Su. S. et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am. Heart J., 2008, 156, 759, el -7.
- Thaver J., Fischer J.E. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J. Intern. Med., 2009, 265 (4), 439 47.
- Singh P., Hawkley L.C., McDade T.W. et al. Autonomic tone and C-reactive protein: a prospective population-based study. Clin. Auton. Res., 2009, 19 (6), 367 74.
- Janszky I., Ericson M., Lekander M. et al. Inflammatory markers and heart rate variability in women with coronary heart diseases. J. Intern. Med., 2004, 5, 421 8.
- Hamaad A., Sosin M., Blann A.D. et al. Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability. Clin. Cardiol., 2005, 28 (12), 570 6.
- Nolan R.P., Reid G.J., Seidelin P.H. et al. C-reactive protein modulates vagal heart rate control in patients with coronary artery disease. Clin Sci, 2007, 112 (8), 449 56.
- Lanza G.A., Sgueglia G.A., Cianflone D. et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am. J. Cardiol., 2006, 15, 97 (12), 1702 6.
- Psychari S.N., Apostolou T.S., Iliodromitis E.K. et al. Inverse relation of C-reactive protein levels to heart rate variability in patients after acute myocardial infarction. Hellenic J. Cardiol., 2007, 48 (2), 64−71.
- Shebab A.M., MacFadyen R.J., McLaren M. et al. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart, 2004, 90, 1263 8.
- Aronson D., Mittleman M.A., Burger A.J. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J. Car-diovasc. Electrophysiol., 2001, 12, 294 300.
- Diakakis G.F., Parthenakis F.I., Mavrakis H.E. et al. Association of impaired glucose tolerance with increased heart rate and subclinical inflammation. Hellenic J. Cardiol., 2005, 46 (6), 394 401.
- Anan F., Takahashi N., Nakagava M. et al. High-sensitive C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism, 2005, 54 (4), 552 8.
- Shinohara T., Tacahashi N., Yufu K. et al. Role of interleukine-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35, 1616 23.
- Gonzalez-Clemente J.M., Vilardell С., Broch M. et al. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes. Eur J. Endocrinol., 2007, 157 (1), 31 -8.
- Brunner E.J., Hemingway H., Walker B.R. et al. Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study. Circulation, 2002, 106, 2659 65.
- Sajadieh A., Nielsen O.W., Rasmussen V. et al. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J. Intern. Med., 2006, 260 (4), 377 87.
- Evrengul H., Dursunoglu D., Cobankara V. et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004- 24(4): 198−202.
- Парнес Е.Я., Красносельский М. Я., Цурко B.B. и др. Долгосрочный прогноз у больных ревматоидным артритом в зависимости от исходной вариабельности сердечного ритма. Тер Архив 2005- 9:77−80.
- Stojanovich L., Milovanovich В., de Luka S.R. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus 2007- 16(3): 181−5.
- Anichkov D.A., Shostak N.A., Ivanov D.S. Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients. Int J Clin Pract 2007- 61:777−83.
- Novikova D.S., Popkova T.V., Gavva T.N. et al. Comparative evaluations of heart rate variability parameters, disease activity and markers of inflammation in patients with rheumatoid arthritis. Ann Rheum Dis 2008- 67(suppl II):308.
- Alkaabi J.K., Ho M., Levison R. et al. Rheumatoid arthritis and macrovascular disease. Rheumatology, 2003, 42, 292 7.
- Goldeli О., Dursun E., Komsuoglu B. et al. Dispersion of ventricular repolarization: a new marker of ventricular arrhythmias in patients with rheumatoid arthritis. J. Rheumatol., 1998, 25(3), 447 50.
- Pirildar Т., Sekuri C., Utiik O. et al. QT dispersion in rheumatoid arthritis patients with and without Sjogren’s syndrome. Clin. Rheumatol., 2003, 22(3), 225 8.
- Cindas A., Gok9e-Kutsal Y., Tokgozoglu L. et al. QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand. J. Rheumatol., 2002, 31(1), 22−6.
- M.C. Кочкина, Д. А. Затейщиков, Б. А. Сидоренко. Измерение жесткости артерий и ее клиническое значение. Кардиология, 2005, 1, 63 71.
- Бойцов С.А. Сосуды как плацдарм и мишень артериальной гипертонии. Consilium Medicum, 2006, 3, 214 7.
- Орлова Я.А., Агеев А. Ф. Жесткость артерий как интегральный показатель сердечно-сосудистого риска: физиология, методы оценки и медикаментозной коррекции. Сердце, 2006, 2, 65 9.
- Laurent S., Cockcroft J., Van Bortel L. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications European Heart Journal, 2006, 27, 2588−605.
- Лопатин Ю.М., Илюхин O.B. Контроль жесткости сосудов. Клиническое значение и способы коррекции. Сердце, 2007, 6, 128 32
- В.Э. Олейников, И. Б. Матросова, Н. В. Борисочева. Клиническое значение исследования ригидности артериальной стенки. Часть I. Кардиология, 2009, 1, 59 64.
- Avest Е. Т., Stalenhoef A. F., De Graaf J. What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction? Clin. Sci., 2007, 112, 507- 16.
- Котовская Ю.В., Кобалава Ж. Д. Анализ пульсовой волны: новая жизнь старого метода. Сердце, 2007, 6, 133−8.
- Новикова Д.С., Попкова Т. В., Мач Э.С., Насонов E.JI. Ригидность артерий -интегральный показатель сердечно-сосудистого риска у больных ревматоидным артритом. Научно-практическая ревматология 2009- 5:38−48.
- Heffernan K.S., Karas R.H., Kuvin J.T. Carotid artery stiffness, high-density lipoprotein cholesterol and inflammation in men with pre-hypertension. J. Hum. Hypertens., 2009, epub ahead of print.
- Lieb W., Larson M.G., Benjamin E. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. J. Circul., 2009, 119, 37 43.
- De Silva D.A., Woon F.P., Gan H.Y. Arterial stiffness, metabolic syndrome and inflammation amongst Asian ischaemic stroke patients. Eur. J. Neurol., 2008, 15, 872 -5.
- Lee Y.J., Lee J.W., Kim J.K. Elevated white blood cell count is associated with arterial stiffness. Nutr. Metab. Cardiovasc. Dis., 2009, 19, 3 7.
- Schnabel R., Larson M.G., Dupuis. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. J Hypertension, 2008,51,1651 7.
- Nakhai-Pour H.R., Grobbee D.E., Bots M.L. C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community. J. Hum. Hypertens., 2007, 21, 949 55.
- Tsioufis C., Dimitriadis K., Selima M. Low-grade inflammation and hypoadi-ponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur. Heart J., 2007, 28, 1162 9.
- Pietri P., Vyssoulis G., Vlachopoulos C. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J. Hypertens., 2006, 24, 2231 8.
- Mahmud A., Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension, 2005, 46, 1118 22.
- Kullo I.J., Seward J.B., Bailey K.R. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am. J. Hypertens., 2005, 18, 1123 9.
- Nagano M., Nakamura M., Sato K. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis, 2005, 180, 189−95.
- Pirro M., Schillaci G., Savarese G. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia.Eur. J. Clin. Invest., 2004, 34,335 -41.
- Mattace-Raso F.U., van der Cammen T.J., van der Meer I.M. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. 2004, 176, 111 6.
- YasminY., McEniery C.M., Wallace S. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler. Thromb. Vase. Biol., 2004, 24, 969 74.
- Tsai W.C., Lin C.C., Huang Y.Y. Association of increased arterial stiffness and inflammation with proteinuria and left ventricular hypertrophy in non-diabetic hypertensive patients. Blood Press., 2007, 16, 270 5.
- Klocke R., Cockcroft J.R., Taylor G.J. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann. Rheum. Dis, 2003, 62,414−8.
- Turesson C, Jacobsson L, Ryde A. Increased stiffness of the abdominal aorta in women with rheumatoid arthritis. Rheumatology, 2005, 44, 896 901.
- Roman M. J, Devereux R. B, Schwartz J.E. Arterial stiffness in chronic inflammatory diseases. Hypertension, 2005, 46, 194 199.
- Maki-Petaja K. M, Hall F. C, Booth A.D. et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation, 2006, 114, 1185 92.
- Wong M., Toh L., Wilson A. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis & Rheum., 2003, 48, 81 -9.
- Avalos I., Chung C.P., Oeser A. Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J. Rheumatol., 2007, 34, 2388−94.
- Van Doornum S., McColl G., Jenkins A. et al. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum., 2003, 48, 72 80.
- Provan SA, Semb AG, Hisdal J, Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis. 2011 May-70(5):812−7
- Насонов E.JI., Каратеев Д. Е. Перспективы применения моноклональных антител к В-лимфоцитам (ритуксимаб) при ревматоидном артрите. Клин, фар-макол. тер., 2006, 15 (1), 55−58.
- Barnabe С., Martin В.J., Ghali W.A. Systematic review and meta-analysis: antitumor necrosis factor a therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res. (Hoboken)., 2011- 63(4): 522−529.
- Irace C., Mancuso G., Fiaschi E. et al. Effect of anti TNF-a therapy on arterial diameter and wall shear stress and HDL cholesterol. Atherosclerosis, 2004, 177, 113 118.
- Lazzerini P.E., AcampaM., HammoudM. Arrythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. J. Rheum., 2008, 35 (10), 1958 65.
- Singh M., Diwan M.M., Patel K.C. A rare case of supraventricular tachycardia induced by Infliximab: a case report. Cases J. 2009- 5−2:147.
- Novikova DS, Popkova TV, Nasonov EL. The effect of anti-B-cell therapy on the development of atherosclerosis in patients with rheumatoid arthritis. Curr Pharm Des. 2012−18(11):1512−8.
- Kerekes G, So^sz P, Бёг H, et al. Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis. Clin Rheumatol 2009- 28: 705−10.
- Raterman HG, Han NM et al. Rituximab alters the HDL particle from a proinflammatory property in good responding rheumatoid arthritis patients. Arthritis Rheum, 2010- 62 (suppllO): 332
- Т.В.Попкова, Д. С. Новикова, О. Г. Линева и соавт. Влияние ритуксимаба на систему транспорта холестерина крови у больных ревматоидным артритом. Научно-практическая ревматология 2010- 4:26−31.
- Ревматология. Клинические рекомендации. Под ред. акад. РАМН Насонова Е. Л. М., ГЭОТАР-Медиа, 2010.
- Распространенность ревматических заболеваний в популяциях взрослого населения России и США. О. М. Фоломеева, Е. А. Галушко, Ш. Ф. Эрдес. Научно-практическая ревматология 2008- 4: 4 13.
- Распространенность ревматоидного артрита в России (по данным эпидемиологического исследования). Е. А. Галушко, Ш. Ф. Эрдес, Д. И. Базоркина и соавт. Терапевтический архив 2010- 5: 9 -14.
- Gabriel S.E. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum. Dis 2008- 67 (Suppl 3): 30−34.
- Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 2002−14: 115−20.
- Jacobsson L.T., Knowler W.C., Pillemer S. et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993−36:1045−1053.
- Lindqvist E., Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999- 58:11−14.
- Pincus Т., Sokka Т., Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum 2001- 44: 1234−1236.
- Riise Т., Jacobsen B.K., Gran J.T. et al. Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin. Rheumatol 2001- 20:123−127.
- Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008−26(5 Suppl 51):S35−61.
- Holmqvist ME, Wedren S, Jacobsson LT, et al. Rapid increase in myocardial infarction risk following diagnosis of RA amongst patients diagnosed between 1995 and 2006. J Intern Med 2010- 268: 578−85.
- Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthri-tis.Rheumatology (Oxford). 2006−45 Suppl 4: iv4−7.
- Pappas D.A., Taube J.M., Bathon J.M., Giles J.T. A 73-Year-Old Woman With Rheumatoid Arthritis and Shortness of Breath. Arthritis & Rheumatism 2008- 59 (6), 892−9.
- Kobayashi Y. et al. Assessment of myocardial abnormalities in RA using comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther., 2010−12(5):R171.
- Recio-Mayoral A. et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J., 2009--30(15): 1837−43.
- Raza K, Banks M, Kitas GD. Reversing myocardial microvascular disease in a patient with rheumatoid arthritis J Rheumatol. 2005 Apr-32(4):754−6.
- Hippisley-Cox J, Coupland C, Robson J, Brindle P. Atrial fibrillation and rheumatoid arthritis are cardiovascular risk factors.BMJ. 2012 Mar 27−344:e2259. doi: 10.1136/bmj.e2259.
- Колотова Г. Б., Гришина И. Ф. Нарушения ритма и проводимости сердца у пациентов с серопозитивным и серонегативным ревматоидным ревматоидным артритом. Ультразвуковая и функциональная диагностика 2008−2:64−9.
- Athern М., Lever J.V., Cosh J. Complete heart block in rheumatoid arthritis. Ann Rheum Dis 1983- 42:389−97.
- Ozgiil M., Ho§ can Y., Arslan C., Karabacak M. Complete atrioventricular block in a patient with rheumatoid arthritis. Turk Kardiyol Dern Ars 2008- 36(4):263−5.
- Okada Y., Nakanishi I., Kajikawa K., Kawasaki S. An autopsy case of rheumatoid arthritis with an involvement of the cardiac conduction system. Jpn Circ J 1983- 47:671−6.
- Han C., Robinson D.W., Hackett M.V. et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J. Rheumatol., 2006, 33, 2167 72.
- Nicola P.J., Crowson C.S., Maradit-Kremers H. et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006- 54: 60−67.
- Goodson N.J., Wiles N.J., Lunt М. et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002- 46: 2010−2019.
- Heliovaara M., Aho K., Knekt P. et al. Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis 1995- 54: 811−814.
- Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F. Cardiovascular, rheuma-tologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008- 15: 1090−1096.
- Aubry MC, Maradit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007- 34: 937−42.
- Meune С., Wahbi К., Assous N. et al. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. J. Rheumatol 2007- 34: 2005−9.
- Giles J.T., Fernandes V., Lima J.A., Bathon J.M. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 2005−7: 195 207.
- Gazi I.F., Boumpas D.T., Mikhailidis D.P., Ganotakis E. S. Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin. Exp. Rheumatol 2007−25: 102−111.
- Teir J., Koduri G., Meadows A et al. An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in centres in East Anglia and the South East. Rheumatology (Oxford) 2008- 47:1252−1254.
- Российские рекомендации по диагностике и лечению артериальной гипер-тензии. В кн.: Национальные клинические рекомендации. Сборник/Под. ред. Р. Г. Оганова. 2-е издание. М., Силицея-Полиграф, 2009, 292 — 332.
- Panoulas V.F., Douglas K.M.J., Milionis H.J. et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology, 2007, 46, 1477 82.
- Panoulas V.F., Metsios G.S., Pace A.V. et al. Hypertension in rheumatoid arthritis. Rheumatology, 2008, 47, 1286 98.
- Naranjo A., Sokka Т., Descalzo M.A. et al.- f-RA Group. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthr. Res. Ther., 2008, 1,30.
- Попкова T.B., Новикова Д. С., Писарев B.B. и соавт. Факторы риска кар-диоваскулярных заболеваний при ревматоидном артрите. Научно-практ. ревма-тол., 2009, 3, 4- 11.
- Никитина Н.М., Ребров А. П. Артериальная гипертония у больных ревматоидным артритом. РФК, 2009, 3, 67 70.
- Корягина Н.В., Мясоедова С. Е., Лебедева О. В. и соавт. Особенности артериальной гипертонии при ревматоидном артрите. Сборник материалов V съезда ревматологов России, Москва, 2009, 57.
- Аршин Е.В. Эпидемиология артериальной гипертензии у больных ревматоидным артритом. Научно-практ. ревматол., 2005, 5, 23 6.
- Оганов Р.Г. Г. Я. Масленникова. Сердечно — сосудистые заболевания в Российской Федерации во второй половине XX столетия: тенденции, возможные причины, перспективы. Кардиология, 2000, 6, 4 9.
- Д.С. Новикова, Т. В. Попкова, Е. Л. Насонов / Современные представления о патогенезе и особенности лечения артериальной гипертензии при ревматоидном артрите // Терапевтический архив. 2011. — № 83 (5). — С. 24 — 33.
- Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2011−78(2):179−83.
- Semb AG, Kvien TK, DeMicco DA et al. Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. Arthritis Rheum. 2012 Sep-64(9):2836−46.
- Semb AG et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. 535−44Ann Rheum Dis. 2010 Nov-69(l 1): 1996−2001.
- Scott 1С, Ibrahim F, Johnson D, Scott DL, Kingsley GH. Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol. 2012 Mar-Apr-30(2):228−32.
- Innala L. et al. Cardiovascular events in early RA a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther, 2011 Aug 15−13(4):R131.
- Myasoedova E, Crowson C. S, Kremers H.M.et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011−70(3):482−7.
- Silman A. J, Newman J, MacGregor A.J. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996- 39: 732−735.
- Klareskog L, Padyukov L, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007- 19: 49−54.
- Goodson N. J, Silman A. J, Pattison D.J. et al. Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis. Rheumatology (Oxford) 2004−43: 731−736.
- Papadopoulos N. G, Alamanos Y, Voulgari P.V. et al. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 2005−23: 861−866.
- Saag K. G, Kolluri S, Koehnke R.K. et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996−39:1711−9.
- Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J. Rheumatol 2000- 27: 630−6
- Masdottir B, Jonsson T, Manfredsdottir V. et al. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 2000−39:1202−5.
- Chen Y. et al. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with IHD and myocardial infarction in RA. J Rheumatol 2011−38(5):802−9.
- Escalante A, Haas RW, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005−25- 165(14): 1624−9.
- Crowson CS, Matteson EL, Davis JM 3rd, Gabriel SE. Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013−65(l):71−7.
- Chung C.P., Oeser A., Solus J.F. et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008- 196: 756−763.
- Dessein P.H., Tobias M., Veller M.G. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J. Rheumatol 2006- 33: 2425−2432.
- Dessein P.H., Joffe B.I., Stanwix A.E. Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study. Arthritis Res 2002−4: 12.
- Jacobsson LT, Turesson C, Hanson RL, et al. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 2001- 44: 1170−6.
- Rho YH, Chung CP, Oeser A, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009- 15- 61:1580−5.
- Lopez-Longo FJ, Oliver-Minarro D, de la Torre I, et al. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 2009- 61: 419−24.
- Serelis J. et al. Cardioascular disease is related to hypertension in patients with RA: a greek cohort study. J Rheumatol., 2011 Feb-38(2):236−41.
- Solomon DH, Kremer J, Curtis JR Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010 Nov-69(l 1): 1920−5.
- Ross R. Atherosclerosis an inflammatory disease. Am Heart J 1999- 138(5 Pt 2): S419−20.
- Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003- 91: 3A-6A.
- Montecucco F, Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 2009- 48: 11−22.
- Sattar N, Mclnnes IB. Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Curr Opin Rheumatol 2005- 17: 286−92.
- Lown B., Verrier R.L. Neuronal activity and ventricular fibrillation. N Engl J Med. 1976- 294:1165−70.
- Waxman M.B., Wald R.W., Cameron D. Interaction between the autonomic nervous system and tachycardias in man. Cardiol Clin. 1983- 1:143−85.
- Gwathmey J.K., Warren S.E., Briggs G.M. et al. Diastolic disfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest 1991−87:1023−31.
- Oparil S., Zaman A.M., Calhoun D.A. Pathogenesis of Hypertension. Ann. Intern. Med., 2003, 139, 761 -6.
- Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987−2007). Brain Behav. Immun 2007- 21:736−45.
- Bellinger DL, et al. Sympathetic modulation of immunity: relevance to disease. Cell. Immunol 2008- 252:27−56.
- Viswanathan K, Dhabhar FS. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc. Natl.Acad. Sci. U. S. A 2005- 102:5808−13.
- Miller LE, Justen HP, Scholmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 2000−14:2097−107.
- Lorton D, et al. Changes in the density and distribution of sympathetic nerves in spleens from Lewis rats with adjuvant-induced arthritis suggest that an injury and sprouting response occurs. J. Comp. Neurol 2005- 489:260−73.
- Straub RH, Rauch L, Fassold A, Lowin T, Pongratz G. Neuronally released sympathetic neurotransmitters stimulate splenic interferon-gamma secretion from T cells in early type II collagen-induced arthritis. Arthritis Rheum 2008- 58:3450−60
- Miller LE, Grifka J, Scholmerich J, Straub RH. Norepinephrine from synovial tyrosinehydroxylase positive cells is a strong indicator of synovial inflammation in rheumaatoid arthritis. J. Rheumatol 2002. 29:427−35.
- Straub RH, Harle P. Sympathetic neurotransmitters in joint inflammation. Rheum. Dis.Clin. North. Am 2005- 31:43−59, viii.31.
- Wahle M, et al. Disease activity related catecholamine response of lymphocytes from patients with rheumatoid arthritis. Ann. N. Y. Acad. Sci 1999- 876:287−96.
- Baerwald C, Graefe C, Muhl C, Von Wiehert P, Krause A. Beta 2-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatic diseases. Eur. J. Clin. Invest 1992- 22Suppl 1:42−6
- Lorton D, et al. Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine.Brain Behav. Immun 2009- 23:276−85.
- Baerwald CG, et al. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergicreceptors. Br. J. Rheumatol 1997- 36:1262−9.
- Wahle M, et al. Beta2-adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMC. J. Interferon Cytokine Res 2005- 25:384−94.
- Kuis W, et al. The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav. Immun 1996- 10:387−98.
- Holman A.J., Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton Neurosci., 2008, 143 (1−2), 58 -67.
- Lubahn CL, Schaller JA, Bellinger DL, SweeneyS, Lorton D. The importance of timing ofadrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis. Brain Behav. Immun 2004- 18:563−71.
- Kalamida D, et al. Muscle and neuronalnicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J 2007- 274:3799−845.
- Wess J. Molecular biology of muscarinicacetylcholine receptors. Crit. Rev. Neurobiol 1996−10:69−99.
- Buijs RM, van der Vliet J, Garidou ML, Huitingal, Escobar C. Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS One 2008- 3: e3152.
- Rosas-Ballina M, et al. Splenic nerve is required for cholinergic antiinflammatory pathwaycontrol of TNF in endotoxemia. Proc. Natl. Acad.Sci. U. S. A 2008- 105:11 008−13.
- Gaykema RP, Dijkstra I, Tilders FJ. Subdiaphragmatic vagotomy suppresses endotoxin- induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 1995- 136:4717−20.
- Goehler LE, et al. Vagal paraganglia bindbiotinylated interleukin-1 receptor antagonist: apossible mechanism for immune-to-brain communication. Brain Res. Bull 1997- 43:357−64.
- Hosoi T, Okuma Y, Nomura Y. Electricalstimulation of afferent vagus nerve induces IL-1 beta expression in the brain and activates HPAaxis. Am. J. Physiol. Regul. Integr. Comp. Physiol 2000−279:R141−7.
- Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann. N. Y. Acad. Sei 1998−840:289−300.
- Straub R.H., Pongratz G., Hirvonen H. et al. Acute cold stress in rheumatoid arthritis inadequately activates stress responses and induces an increase of interleukin 6. Ann. Rheum. Dis., 2009, 68(4), 572 8.
- Pongratz G., Zietz B., Gluck T. et al. Corticotropin-releasing factor modulates cardiovascular and pupillary autonomic reflexes in man: is there a link to inflammation-induced autonomic nervous hyperreflexia? Ann. NY Acad. Sei., 2002, 966, 373 -83.
- Arlt J., Jahn H., Kellner M., et al. Modulation of sympathetic activity by cortico-trophin-releasing hormone and atrial natriuretic peptide. Neuropeptides, 2003, 37 (6), 362 8.
- Kemp A.H., Quintana D.S., Gray M.A. et al. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol. Psychiatry 2010- 1−67(11): 1067−74
- Brown A.D., Barton D.A., Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs, 2009, 23 (7), 583 602.
- Carney R.M., Freedland K.E. Depression and heart rate variability in patients with coronary heart disease. Clev. Clin. J. of Med., 2009, 76, S2, S13 SI 7.
- Чернышева Т.Е., Гурьева И. В., Алтунбаев H.A. и др. Диабетическая нейропатия (патогенез, диагностика, лечение). М.: Медпрактика-М, 2005.
- Шальнова С.А., Деев А. Д., Оганов Р. Г. и др. Частота пульса и смертность от сердечно-сосудистых заболеваний у российских мужчин и женщин. Результаты эпидемиологического исследования. Кардиология 2005−10:45−50.
- Copie X., Hnatkova K., Staunton A. et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. J Am Coll Cardiol 1996−27:270−6.
- Palatini P., Julius S. Heart rate and cardiovascular risk. J Hypertens 1997−15:3−17.
- Рябыкина Г. В., Соболев A.B. Анализ вариабельности ритма сердца. Кардиология 1996- 10:87−97.
- Jose A.D., Taylor R.R. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J. Clin. Invest., 1969, 48(11), 2019 31.
- Hirsch J.A., Bishop B. Respiratory sinus arrhythmia in humans: how breathing pattern modulates heart rate. Am. J. Physiol., 1981, 241 (4), 620 9.
- Соколов С.Ф., Малкина Т. А. Клиническое значение оценки вариабельности ритма сердца. Сердце, 2002, 2, 72 5.
- Akselrod S. Power spectrum analysis of heart rate variability in dogs was related to progressive autonomic blockade. References also to original studies by Sayers on the spectral components of heart rate variability. Science, 1981, 213, 221 4.
- Akselrod S. Components of heart rate variability. Basic Studies. From: Malik M, Camm A.J.: Heart rate variability. Armonk, Futura Publishing Company, Inc., 1995, 147 60.
- Akselrod S. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science, 1981, 213, 220 2.
- Bigger J.T. Components of heart rate variability measured during healing of acute myocardial infarction. Am. J. Cardiol, 1988, 18, 464 72.
- Malik M, Camm A.J. Heart rate Variability. Clin. Cardiol, 1990, 13, 570 576.
- Макаров JI.M. Противоречивые аспекты анализа вариабельности ритма сердца при холтеровском мониторировании. Клинические и физиологические аспекты ортостатических расстройств. М, 2001, 89−93.
- Umetani К, Singer D. H, NcCarty R, Atkinson M. Twenty four hour time domain heart rate variability and heart rate: relation to age and gender over nine decades. JACC 1998- 31:593−601.
- Sosnowski M, Korzeniowska B, Skrzypek-Wanna J. et al. HRV adjustment for age and mean RR interval disclose a different prognostic value of HRV measure in men and women with coronary heart disease. Eur Heart J 2002- 4 (abstract suppl.):408.
- Соколов С. Ф, Малкина T. A, Алексеева Ю. М. и соавт. Показатели вариабельности ритма сердца в норме у взрослых: коррекция по возрасту и частоте сердечных сокращений. Функциональная диагностика 2007- 3:6−16.
- Пшеничников И, Шипилова Т, Карай Д. и соавт. Связь интервала QT и дисперсии интервала QT с факторами, определяющими прогноз сердечнососудистой заболеваемости и смертности в популяции женщин 56—65 лет города Таллин. Кардиология 2009−4:46−51.
- Janse van Rensburg DC, Ker JA, Grant CC, Fletcher L. Autonomic impairment in rheumatoid arthritis. Int J Rheum Dis. 2012 Aug- 15(4):419−26.
- Vlcek M, Rovensky J, Eisenhofer G, Autonomic nervous system function in rheumatoid arthritis. Cell Mol Neurobiol. 2012 Jul-32(5):897−901. Epub 2012 Feb 5.
- Ker JA, Grant CC, Fletcher L.Int J Rheum Dis. 2012 Aug- 15(4):419−26. Autonomic impairment in rheumatoid arthritis.
- Mussalo H., Vannien E., Ikaheimo R. et al. Heart rate variability and its determinants in patients with severe or mild essential hypertension. Clin Physiol., 2001, 21,594−604.
- Dietrich D., Schindler C., Schwartz J. et al. Heart rate variability in an ageing population and its association with lifestyle and cardiovascular risk factors: results of the SAPALDIA study. Europace, 2006, 8, 521 9.
- Guizar J.M., Ahuatzin R., Amador N. Heart autonomic dysfunction in overweight adolescents. Indian Pediatr., 2005, 42 (5), 464 9.
- Sloan R.P., Huang M.H., McCreath H. et al. Cardiac autonomic control and the effects of age, race, and sex: the CARDIA study. Auton. Neurosci., 2008, 30, 78 85.
- Никитина H.M., Ребров А. П. Взаимосвязь показателей вариабельности ритма сердца и толщины интима-медиа сонных артерий у больных ревматоидным артритом. Сб. матер. V съезда ревматологов России, 2009, 80.
- Lopez de Guzman A, de D Garcia Diaz J, Diez-Perez de la Vacas MI et al. Coronary calcification and subclinical myocardial dysfuncion in rheumatoid arthritis Rev Clin Esp 2009- 209(9):428−32.
- Yavuzkir M., Ozturk A., Dagli N. et al. Effect of ongoing inflammation in rheumatoid arthritis on P-wave dispersion. J. Int. Med. Res., 2007, 35(6), 796 802.
- Tillin Т., Chambers J., Malik I. Measurement of pulse wave velocity: site matters. J. Hypertens., 2007, 25, 383 9.
- Клинические рекомендации Европейского общества кардиологов 2007 г. М., 2008- 186 с.
- Millasseau S.C., Kelly R.P., Ritter J.M., Chowienczyk P.J. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond) 2002−103(4):371−7.
- Millasseaua S.C., Ritter J.M., Takazawab K., Chowienczyka P.J. Contour analysis of the photoplethysmographic pulse measured at the finger. Journal of Hypert 2006−24:1449−56.
- Dawber T.R., Thomas H.E., McNamara P.M. Characteristics of the dicrotic notch of the arterial pulse wave in coronary heart disease. Angiology 1973−24:244−255.
- Park S., Lakatta E.G. Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J 2012−53(2):258−61.
- Wallberg-Jonsson S., Caidahl K., Klintland N. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis. Scand. J. Rheumatol., 2008, 37, 1 5.
- Inaba M., Tanaka K., Goto H. Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. J. Rheumatol., 2007, 34, 290−5.
- Ryden A.A., Lanne Т., Wollmer P. Increased arterial stiffness in women, but not in men, with IDDM. Diabetologia, 1995, 38, 1082 9.
- Gabriel S.E., Crowson C.S., Kremers H.M. et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum., 2003, 48, 54−8.
- Rasmussen Т.Е., Hallett J.W., Tazelaar H.D. et al. Human leukocyteantigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aorticaneurysms. J. Vase. Surg., 2002, 35, 988 93.
- Кардиология. Нац. руководство. Под ред. Ю. Н. Беленкова, Р. Г. Оганова, М.: Гэотар Медиа, 2007, 1232с.
- Chen К., Lindsey J.B., Khera A. Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study. Diab. Vase. Dis. Res., 2008, 5, 96 101.
- Chung С. P., Oeser A., Joseph F. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis, 2008, 196, 756 63.
- Ревматология: национальное руководство/ под ред. Насонова E. JL, Насоновой В .А., М.: Гэотар-Медиа, 2008., 720 с.
- Jacobsson L.T., Askling J., Rantapaa-Dahlgvist S. Anti-TNF therapy and risk of death up to 8 years after treatment start. Results from the Swedish biologies register (ARTIS). Ann Rheum Dis 2008- 67 (suppl II): 183.
- Jacobsson L.T., Turesson C., Gulfe A. et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005- 32: 1213 -1218.
- Suissa S., Bernatsky S., Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 2006 55: 531 536.
- Solomon D.H., Avorn J., Katz J.N. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum., 2006, 54, 3790 3798.
- Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by В cells of hypercholesterolemic mice. J Clin Invest 2002- 109: 745−53.
- Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vase Biol 2002- 22: 1892−8.
- Watanabe M., Sangawa A., Sasaki Y. et al. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J. Atheroscler. Thromb., 2007, 14, 325−331
- Aubry M.C., Riehle D.L., Edwards W.D. et al. B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. Cardiovasc. Pathol., 2004, 13, 233−236.
- Kyaw T, Tay C, Krishnamurthi S, Kanellakis P. Bla B lymphocytes are athero-protective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011- 109: 830−40.
- Kyaw T, Tay C, Khan A, et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010- 185: 4410−9.
- Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010- 207: 1579−87.
- Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008- 20: 332−8.
- Harris DP, Haynes L, Sayles PC, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000- 1: 475−82.
- Rituximab. Available from: www.accessdata.fda.gov/scripts/cder/drugsatfda.
- Millward PM, Bandarenko N, Chang PP et al. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab. Transfusion 2005- 45: 1481−6.
- Poterucha JT, Westberg M, Nerheim P, Lovell JP. Rituximab-induced polymorphic ventricular tachycardia. Tex Heart Inst J 2010- 37: 218−20.
- DI Franco M, Paradiso M, Ceccarelli F Biological drug treatment of rheumatoid arthritis and spondylarthritis: effects on QT interval and QT dispersion. J Rheumatol. 2012−39(l):41−5.
- Provan S.A., Angel K., Odegard S et al. Early inflammation can predict arterial stiffness: a 5-year longitudinal study of 238 patients with rheumatoid arthritis. Ann. Rheum. Dis., 2008, 67 (suppl II), 310.
- Angel K., Provan S.A., Agewall S. et al. TNF-alpha antagonists reduce arterial stiffness in patients with rheumatoid arthritis and related arthropaties: a controlled study. Ann. Rheum. Dis., 2008, 67 (suppl II), 160.
- Wong M., Oakley S.P., Young L. Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis. 2009−68(8): 1277−84.
- Maki-Petaja K.M., Wilkinson I.B. Anti-inflammatory drugs and statins for arterial stiffness reduction. Curr. Pharm. Des., 2009, 15, 290 303.
- Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D. Effect of 1 -year anti-TNF-a therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens. 2012−25(6):644−50.
- Mathieu S, Pereira B, Dubost JJ, Lusson JR, Soubrier M. No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment. (Oxford). 2012−51(6):1107−11.
- Arnett F.C., Edworthy S.M., Bloch D.A. The ARA 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988−31:315−24.
- Alberti K.G., Zimmet P., Shaw J. et al. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005- 366: 1059−1062.
- Smolen J.S., Breedveld F.C., Schiff М.Н. et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003- 42: 244−257.
- Рябыкина Г. В. Диагностика ишемии миокарда методом холтеровского мо-ниторирования ЭКГ. Вестник аритмологии. 2002- 26: 5−9.
- Российские рекомендации по диагностике и лечению артериальной гипер-тензии. В кн.: Национальные клинические рекомендации: Сборник. Под ред. Оганова Р. Г. 2-е изд. М.: Силицея-Полиграф, 2009−292−332.
- Российские рекомендации по диагностике и лечению хронической сердечной недостаточности (третий пересмотр). Сердечная недостаточность 2010−11,1(57).
- Haward G., Sharrett A.R., Heiss G. et al. Carotid artery intima-media thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993−24:1297−1304.
- Герасимов A.H. Медицинская статистика. M.: ООО «Медицинское информационное агентство» 2007- 480с.
- Крамер Г. Математические методы статистики, пер. с англ., 2 изд. М., 1975.
- Верткин A. JL, Мартынов И. В., Гасилин B.C. и соавт. Безболевая ишемия миокарда. М., 1995. — 85 с.
- Callaham P.R., Froelicher V.F., Klein Y. et al. Exercise induced silent ischemia: Age, diabetes mellitus, previous myocardial infarction and prognosis. JACC 1989−14:1175−1180.
- Cohn P.F., Fox K.M., Daly C. Silent myocardial ischemia. Circulation 2003−108: 1263−1277.
- Fleg J.L., Gersterblith G., Zonnerman A.B. et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 1990−81:428−6.
- Mark D.B., Hlatky M.A., Califf R.M. et al. Painless exercise ST deviation on the treadmill: Long-term prognosis. J. Amer. Coll. Cardiology 1989- 14: 885−892.
- Schroeder A.P., Brysting В., Sogaard P., Pedersen O.L. Silent myocardial is-chaemia in untreated essential hypertensives. Blood Press 1995−4: 97−104.
- Trivoni D., Stern S. Prognostic significance and therapeutic implications of silent myocardial ischemia. Europ. Heart J 1990- 11: 288−293.
- Дабровски А., Дабровски Б., Пиотрович P. Суточное мониторирование ЭКГ: (Перевод: Корнеев Н. В., Грабко Н. Н., Банникова С.Д.) М.: 2000. — 208с.
- Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M. Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol. 2013−42(2):131−5.
- Davis JM 3rd, Maradit Kremers H, Crowson CS. et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007 Mar-56(3):820−30.
- Mazzantini M, Talarico R, Doveri M et al. Incident comorbidity among patients with rheumatoid arthritis treated or not with low-dose glucocorticoids: a retrospective study. J Rheumatol. 2010−37(11):2232−6.
- Khovidhunkit W., Kim M.S., Memon R.A. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004−45:1169 96.
- Stavropoulos-Kalinoglou A, Metsios G. S, Koutedakis Y. et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann. Rheum. Dis, 2007, 66, 1316−21.
- Kumari R, Uppal S.S. First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature. Rheumatol Int 2005- 26(l):70−3.
- Rozman B, Praprotnik S, Logar D. et al. Leflunomide and hypertension. Ann Rheum Dis 2002−61:567−9.
- Alcorn N, Saunders S, Madhok R. Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing. Drug Saf. 2009−32(12): 1123−34.
- Попкова T. B, Хелковская A. H, Мач Э. С. и др. Сердечно-сосудистые заболевания при ревматоидном артрите. Тер Архив- 2007- 5:9−14.
- Попкова Т. В, Новикова Д. С, Насонов E.JI. Кардиоваскулярные факторы риска при ревматических заболеваниях: связь с воспалением. Consilium medicum 2010- 2:112−118.
- Sidiropoulos P. I, Karvounaris S. A, Boumpas D. T. Metabolic syndrome in rheumatic disease: epidemiology, pathophysiology, and clinical implications. Arthr Research Therapy 2008- 10:207.
- Mancia G, Bousquet P, Elghozi J et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007- 25:909−20.
- Tentolouris N, Liatis S, Katsilambros N. Syspathehic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci 2006- 1083:129−52.
- Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003- 88(6):2404-l 1.
- Брагина A. E, Салимжанова Ю. Н, Панфилова Е. Ю, Фомина И. Г. Состояние ренин-ангиотензин-альдостероновой системы у женщин с артериальной гипертензией в климактерическом периоде. Кардиоваскул. тер. и профилак. 2005- 4(6):92−7.
- Ash-Bernal R, Peterson LR. The cardiometabolic syndrome and cardiovascular disease. J Cardiometab Syndr 2006−1:25−8.
- Alpert MA. Obesity cardiomyopathy: patophysiology and evolution of clinical syndrome. Am J Med Sci 2001- 321(4): 1213−9.
- Liao D., Sloan R.P., Cascio W.E. et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998- 21:2116−22.
- Hemingway H., Shipley M., Brunner E. et al. Does autonomic function link social position to coronary risk? The Whitehall II study. Circulation 2005- 111:3071−7.
- Stein P.K., Barzilay J.I., Domitrovich P.P. et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels the metabolic syndrome: the Cardiovascular Health Study. Diabet Med 2007- 24:855−63.
- Хурс E.M., Андреев П. В., Поддубная A.B. и соавт. Вегетативный дисбаланс в патогенезе метаболического синдрома. Клиническая медицина 2010- 6: 39−43.
- Min К.В., Min J.Y., Paek D., Cho S.I. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol 2008- 31(5):584−91.
- Assoumou H.G., Pichot V., Barthelemy J.C. et al. Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: the PROOF study. Rejuvenation Res 2010- 13(6):653−63.
- Невзорова, В. А., Абрамов, E. А., Власенко, A. H. Особенности липидного спектра, вариабельности артериального давления и сердечного ритма у больных с клиническими проявлениями метаболического синдрома. Вестник арит-мологии 2004- 36:27−30.
- Кратнов А.Е., Климачева О. В., Третьяков С. В. Влияние факторов метаболического синдрома на изменение вариабельности ритма сердца. СТМ 2011- 3:102−5.
- Gehi A., Lampert R., Veledar E. et al. A twin study of metabolic syndrome and autonomic tone. J Cardiovasc Electrophysiol 2009- 20(4):422−8.
- Manolio T.A., Pearson T.A., Wenger N.K., et al. Cholesterol and heart disease in older persons and women. Rewiew of an NHLBI workshop. Ann Epidemiol 1992- 2:161−76.
- Bass K.M., Newschaffer C.J., Klag M.J., Bush T. L. Plasma lipopritein levels as predictors of cardiovascular death in women. Arch Intern Med 1993- 153:2209−16.
- Gonzalez-Gay M. A, De Matias J. M, Gonzalez-Juanatey C. et al. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006- 24:83−6.
- Pirintr P, Chansaisakorn W, Trisiriroj M, Kalandakanond-Thongsong S, Buranakarl C. Heart rate variability and plasma norepinephrine concentration in diabetic dogs at rest. Vet Res Commun. 2012 Dec-36(4):207−14.
- Maule S, Rabbia F, Perni V et. al. Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension. Hypertens Res. 2008 Nov-31(11):2003−10.
- Gunarathne A., Patel J.V., Hughes E.A., Lip G.Y. Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification. Am J Hypertens 2008−21(8):866−72.
- Gerli R., Bartolom Bocci E., Sherer Y. et al. Association of anti-cyclic citrulli-nated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann. Rheum Dis 2008−67:724−725.
- Giles J.T., Malayeri A.A., Fernandes V. et al. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthr Rheum 2010−62(4):940−51.
- Van Popele N.M., Grobbee D.E., Bots M. et al. Association between arterial stiffness and atherosclerosis. Stroke 2001−32:454−60.
- Chen J.Y., Tsai W.C., Lin C.C. et al. Stiffness index derived from digital volume pulse as a marker of target organ damage in untreated hypertension. Blood Press 2005- 14(4):233−7.
- Kiortsis DN, Mavridis AK, Filippatos TD Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol. 2006−33(5):921−3.
- Spanakis E, Sidiropoulos P, Papadakis J, Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol. 2006 Dec-33(12):2440−6.
- Cauza E, Cauza K, Hanusch-Enserer U, Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis. Wien Klin Wochenschr. 2002−30−114(23−24): 1004−7.
- Da’ien CI, Duny Y, Barnetche T, Daures JP, Combe B, Morel J. Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with metaanalysis. Ann Rheum Dis. 2012−71(6):862−8.
- Tomasson G., Aspelund T., Jonsson T. et al. The effect of rheumatoid factor on mortality and coronary heart disease Ann. Rheum. Dis., 2010, 69 (9), 1649 54.
- Goodson N.I., Willes N.J., Lunt N.C. Mortality on early inflammatory arthritis: cardiovascular mortality in seropositive patients. Arhtritis Rheum 2002, 46, 2010−9.
- Del Porto F., Lagana B., Lai S. et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford). 2007−46(7):1111−5.
- Ferrante A., Giardina A.R., Ciccia F. et al. Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatol Int. 2009−30(2): 193−8.
- Di Micco P., Ferrazzi P., Libre L. et al. Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis. Int J Gen Med. 2009−30−2:141−4.
- Jin T., Bokarewa M., Amu S., Tarkowski A. Impact of short-term therapies with biologies on prothrombotic biomarkers in rheumatoid arthritis. Clin Exp Rheumatol. 2009−27(3):491−4.
- Narvaez J., Diaz-Torne C., Ruiz J.M. et al. Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs. Clin Exp Rheumatol. 2011−29(6):991−7.
- Klaasen R., Cantaert T., Wijbrandts C.A. et al. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study. Rheumatology (Oxford) 2011−50(8): 1487
- Canhao H., Rodrigues A.M., Mourao A.F. et al. Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis. Rheumatology (Oxford) 2012−51(ll):2020−6.93.